Our Vision

Our
Vision

OUR SINGULAR FOCUS:
TO ADVANCE CELL THERAPIES TO CURE CANcER

Inceptor Bio is committed to confronting one of humanity’s single most complex problems — difficult-to-cure cancers. Every day, we are working to enable patients with these cancers to realize what was once an impossible dream — to be cured.

Led by scientific and industry pioneers, Inceptor Bio is developing next-generation cell therapy programs with a focus on chimeric antigen receptor (CAR) constructs, which have novel mechanisms to enhance immune cell activation and endurance in the tumor microenvironment (TME).

We are developing best-in-class therapies – our CAR-T, CAR-M, CAR-NK platform technologies – to enhance the likelihood of success against difficult-to-treat cancers.

Inceptor Bio has built a team that has deep industry expertise. What draws this team together is a shared passion to realize the tremendous potential of cell and gene therapies to deliver cures for cancer patients.

A key pillar of Inceptor Bio’s strategy is alleviating what has been a major bottleneck for cell therapies – access to early-phase manufacturing. We have established our Advanced Manufacturing Platform (AMP+), based in Gainesville, Florida.